SCHEMBL9684575

SCHEMBL9684575

c1ccc(Cn2cc3ccsc3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
HPGD P15428 3/20 0.37
MAPT P10636 4/20 0.37
POLB P06746 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP19A1 P11511 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
TBXAS1 P24557 1/20 0.37
QPCT Q16769 1/20 0.37
CYP4Z1 Q86W10 1/20 0.37
QPCTL Q9NXS2 1/20 0.37
THRB P10828 1/20 0.37
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 3/20 0.36
HSD17B10 Q99714 3/20 0.36
G6PD P11413 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12952428 0.73 CYP2A6 (0.33)
SCHEMBL9684263 0.70 CYP2A6 (0.32) POLBCYP2D6
SCHEMBL9683487 0.68 CTNNB1 (0.33) ALDH1A1HPGDMAPTPOLBCYP1A2
SCHEMBL5490865 0.66 CYP19A1 (0.45) ALDH1A1HPGDMAPTPOLBCYP1A2
SCHEMBL3725873 0.66 HPGD (0.46) ALDH1A1HPGDMAPTPOLBCYP1A2
SCHEMBL31212412 0.65 CYP19A1 (0.44) ALDH1A1MAPTPOLBCYP1A2CYP3A4
SCHEMBL28080846 0.65 HPGDS (0.49) ALDH1A1MAPTPOLBCYP1A2CYP3A4
SCHEMBL14985293 0.64 HTR6 (0.43) ALDH1A1HPGDMAPTPOLBCYP2D6
SCHEMBL30912787 0.64 CYP19A1 (0.49) ALDH1A1MAPTPOLBCYP1A2CYP3A4
SCHEMBL182699 0.64 CYP2D6 (0.51) ALDH1A1HPGDMAPTPOLBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0475187-A1 Naphthothiophenimines for treating neuronal disorders caused by ischemia BRISTOL-MYERS SQUIBB COMPANY (US) 1992-03-18 EP disclosed
US-5064831-A N-methyl-d-aspartate receptor antagonist BRISTOL-MYERS SQUIBB CO. (US) 1991-11-12 US disclosed